Answers are grounded in this paper and cite their sources.
Neurosurgeons are familiar with chronic subdural haematoma (CSH), a well-known clinical entity, which is usually treated by some modality of trepanation. Despite the excellent outcomes obtained by surgery, complications may occur, some of which may be potentially severe or fatal. Furthermore, up to 25% recurrence rate is reported. The authors present a novel approach to the management of CSH based on the use of dexamethasone as the treatment of choice in the majority of cases.
No takes yet. Share an insight, caveat, or question.
Delgado‐López et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: